These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
5. Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer. Cao D; Song Q; Li J; Jiang Y; Wang Z; Lu S Expert Rev Mol Med; 2021 Dec; 23():e21. PubMed ID: 34906271 [TBL] [Abstract][Full Text] [Related]
6. A systematic overview of chemotherapy effects in breast cancer. Bergh J; Jönsson PE; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936 [TBL] [Abstract][Full Text] [Related]
7. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer. Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263 [TBL] [Abstract][Full Text] [Related]
8. Multi-agent chemotherapy for early breast cancer. Early Breast Cancer Trialists' Collaborative Group Cochrane Database Syst Rev; 2002; (1):CD000487. PubMed ID: 11869577 [TBL] [Abstract][Full Text] [Related]
9. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma]. Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995 [TBL] [Abstract][Full Text] [Related]
10. Combinational therapy: new hope for pancreatic cancer? Shi S; Yao W; Xu J; Long J; Liu C; Yu X Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436 [TBL] [Abstract][Full Text] [Related]
11. Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment. Polireddy K; Chen Q J Cancer; 2016; 7(11):1497-514. PubMed ID: 27471566 [TBL] [Abstract][Full Text] [Related]
12. Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining? Hua J; Shi S; Liang D; Liang C; Meng Q; Zhang B; Ni Q; Xu J; Yu X Onco Targets Ther; 2018; 11():4591-4608. PubMed ID: 30122951 [TBL] [Abstract][Full Text] [Related]
13. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts. Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495 [TBL] [Abstract][Full Text] [Related]
14. The curability of breast cancer and the treatment of advanced disease. Guarneri V; Conte PF Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948 [TBL] [Abstract][Full Text] [Related]
15. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574 [TBL] [Abstract][Full Text] [Related]
17. Case report: Irreversible electroporation for locally advanced pancreatic cancer. Orcutt S; Kis B; Malafa M Int J Surg Case Rep; 2017; 40():54-57. PubMed ID: 28941969 [TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Martin RC; McFarland K; Ellis S; Velanovich V Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941 [TBL] [Abstract][Full Text] [Related]
19. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer: progress in cancer therapy. Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]